# ---------------------------------------------------------------
# Boni Lab Malaria Simulation Configuration
# ---------------------------------------------------------------
# This configuration file runs the malaria simulation from year 2000 to year 2030.
# The drug is deployed in year 2010.

# ---------------------------------------------------------------
# 1. Execution Settings
# ---------------------------------------------------------------
execution_settings:
  # Number of model days between updates to the user
  days_between_notifications: 30
  
  # Initial seed number for random number generator; set to 0 or comment out to use a random seed
  initial_seed_number: 0
  
  # Record the genomic data (set to true for a real run)
  record_genome_db: true
  
  # Frequency (in days) to report to GUI and console
  report_frequency: 30

# ---------------------------------------------------------------
# 2. Simulation Timeframe
# ---------------------------------------------------------------
simulation_timeframe:
  # Simulation starting date (calibration year minus 11 years of burn-in)
  starting_date: 2000/1/1
  
  # Start of comparison period (mutations start in 2010)
  start_of_comparison_period: 2010/1/1
  
  # Simulation ending date
  ending_date: 2030/1/1
  
  # Day to start collecting data (discard the first five years of data)
  start_collect_data_day: 0
  
  # Number of days to keep track of the total number of parasites in the population
  number_of_tracking_days: 11

# ---------------------------------------------------------------
# 3. Transmission Settings
# ---------------------------------------------------------------
transmission_settings:
  # Transmission parameter based on data; adjusts the odds that an individual will be infected when challenged by sporozoites
  transmission_parameter: 0.55
  
  # Probability that an infectious bite on a human causes a blood-stage malaria infection
  p_infection_from_an_infectious_bite: 0.1

# ---------------------------------------------------------------
# 4. Population Structure
# ---------------------------------------------------------------
population_structure:
  # Number of age classes used for reporting age-specific mortality calculations
  number_of_age_classes: 15
  
  # Age structure used for reporting (in years)
  age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 15, 20, 60, 100]
  
  # Initial age structure used when initializing the model at T=0
  initial_age_structure: [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 25, 35, 45, 55, 65, 100]
  
  # Scaling factor for the population in the model (based on data)
  artificial_rescaling_of_population_size: 0.25

# ---------------------------------------------------------------
# 5. Raster and Geographic Settings
# ---------------------------------------------------------------
raster_settings:
  # Adjusted population raster to account for burn-in up to 2009 start
  population_raster: "../input/kag_init_pop.asc"
  
  # Raster files defining the country districts
  district_raster: "../input/kag_district.asc"
  
  # Raster files defining treatment probabilities (comment these out for beta calibration)
  pr_treatment_under5: "../input/kag_treatment.asc"
  pr_treatment_over5: "../input/kag_treatment.asc"
  
  # Raster file containing the calibrated beta value
  beta_raster: "../input/kag_beta_r1.asc"
  
  # Cell size used by raster, in square kilometers
  cell_size: 5
  
  # Approximate national age distribution (to be updated with specific country data)
  age_distribution_by_location:
    - [0.0378, 0.0378, 0.0378, 0.0378, 0.0282, 0.0282, 0.0282, 0.0282, 0.0282, 0.029, 0.029, 0.029, 0.029, 0.029, 0.169, 0.134, 0.106, 0.066, 0.053, 0.035, 0.0]
  
  # Probability that an infected and symptomatic person receives treatment; single value for the entire country
  # If set to '-1', these values are read from 'pr_treatment_under5' and 'pr_treatment_over5' above
  p_treatment_for_less_than_5_by_location: [-1]
  p_treatment_for_more_than_5_by_location: [-1]
  
  # Will be overridden by beta_raster
  beta_by_location: [-1]

# ---------------------------------------------------------------
# 6. Seasonality Settings
# ---------------------------------------------------------------
seasonality_settings:
  # Seasonality of malaria (to be updated with specific country data)
  enable: false
  mode: rainfall
  rainfall:
    filename: "rwa_adjustment.csv"
    period: 365

# ---------------------------------------------------------------
# 7. Movement and Spatial Model
# ---------------------------------------------------------------
movement_settings:
  # Country-specific movement model and calibration
  spatial_model:
    name: "Wesolowski"
    Wesolowski:
      kappa: 0.01093251
      alpha: 0.22268982
      beta: 0.14319618
      gamma: 0.83741484
  
  # Settings that determine how long an individual stays in a given location
  circulation_info:
    max_relative_moving_value: 35
    number_of_moving_levels: 100
    moving_level_distribution:
      distribution: Gamma
      Gamma:
        mean: 5
        sd: 10
    
    # Percentage of the population selected for movement outside of their cell each timestep
    circulation_percent: 0.0
    length_of_stay:
      mean: 5
      sd: 10

# ---------------------------------------------------------------
# 8. Demographic Parameters
# ---------------------------------------------------------------
demographic_parameters:
  # Crude birth rate (to be updated with specific country data)
  birth_rate: 0.0288
  
  # Malaria-adjusted all-cause death rate by age class (to be updated with specific country data)
  death_rate_by_age_class:
    - [0.02641, 0.00202, 0.00202, 0.00202, 0.00198, 0.00247, 0.00247, 0.00247, 0.00247, 0.00247, 0.00247, 0.00247, 0.00455, 0.00455, 0.05348]
  
  # Probability of death for patients who are not treated or experience a treatment failure
  # When receiving treatment, this rate drops by a factor of 10 in the code
  mortality_when_treatment_fail_by_age_class:
    - [0.040, 0.020, 0.020, 0.020, 0.020, 0.004, 0.004, 0.004, 0.004, 0.004, 0.004, 0.001, 0.001, 0.001, 0.001]

# ---------------------------------------------------------------
# 9. Parasite Parameters
# ---------------------------------------------------------------
parasite_parameters:
  parasite_density_levels:
    # Standard values used in other models
    log_parasite_density_cured: -4.699       # Corresponds to 100 total parasites (0.00002 per μl)
    log_parasite_density_from_liver: -2.000  # Corresponds to 50,000 total parasites (0.01 per μl)
    log_parasite_density_asymptomatic: 3     # Corresponds to 1,000 parasites per μl of blood
    log_parasite_density_clinical: 4.301     # Corresponds to 20,000 parasites per μl of blood
    log_parasite_density_clinical_from: 3.301  # Corresponds to 2,000 parasites per μl of blood
    log_parasite_density_clinical_to: 5.301    # Corresponds to 200,000 parasites per μl of blood
    log_parasite_density_detectable: 1.000     # Corresponds to 10 parasites per μl of blood
    log_parasite_density_detectable_pfpr: 1.699 # Corresponds to 100 parasites per μl of blood
    log_parasite_density_pyrogenic: 3.398      # Corresponds to 2,500 parasites per μl of blood

  recombination_parameters:
    # Within-chromosome recombination rate
    within_chromosome_recombination_rate: 0.1
    
    # Free recombination among the drug resistance loci
    using_free_recombination: true

# ---------------------------------------------------------------
# 10. Immune System Parameters
# ---------------------------------------------------------------
immune_system_parameters:
  # Parameters governing the immune response
  b1: 0.00125  # Rate at which antimalarial immune function increases when a host is parasitemic
  b2: 0.0025   # Rate at which antimalarial immune function decreases when a host is parasitemic
  duration_for_naive: 300        # Duration of infection for naive hosts
  duration_for_fully_immune: 60  # Duration of infection for fully immune hosts
  mean_initial_condition: 0.1    # Initial immune function mean at time zero
  sd_initial_condition: 0.1      # Initial immune function standard deviation at time zero
  immune_inflation_rate: 0.01    # Age-dependent faster acquisition of immunity from age 1 to age 10 (per year)
  min_clinical_probability: 0.05 # Minimum probability of experiencing symptoms from a new infection
  max_clinical_probability: 0.99 # Maximum probability of experiencing symptoms from a new infection
  immune_effect_on_progression_to_clinical: 5.4 # Slope of the sigmoidal probability vs. immunity function
  age_mature_immunity: 10        # Age at which immune function is mature
  factor_effect_age_mature_immunity: 0.3 # Adjusts the inflection point in the curve
  midpoint: 0.4                  # Midpoint for the immunity curve

# ---------------------------------------------------------------
# 11. Mutation and Genotype Parameters
# ---------------------------------------------------------------
mutation_and_genotype_parameters:
  # Mutation mask indicating positions of genetic mutations
  mutation_mask: "||||111||1111111,0||||||000000000010|1"
  
  # Daily probability that a parasite will mutate at a given locus when drug concentration is not zero
  mutation_probability_by_locus: 0.001
  
  pf_genotype_info:
    - chromosome: 5
      genes:
        - name: "Pfmdr1"
          max_copies: 2
          # copy number variation cost of resistances
          cnv_daily_crs: [ 0, 0.0005 ]
          cnv_multiplicative_effect_on_EC50:
            - drug_id: 4
              factors: [ 1, 2.44444444 ]
            - drug_id: 1
              factors: [ 1, 1.3 ]
          multiplicative_effect_on_EC50_for_2_or_more_mutations:
            - drug_id: 1
              factor: 1.05
          aa_positions:
            - position: 86
              amino_acids: [ 'N', 'Y' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 6
                  factors: [ 1, 1.25 ]
                - drug_id: 1
                  factors: [ 1.25, 1 ]
                - drug_id: 2
                  factors: [ 1, 1.42 ]
            - position: 184
              amino_acids: [ 'Y', 'F' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 1
                  factors: [ 1, 1.25 ] # base*1.25*1.25 0.9375 > 0.8xxx (old value)
                - drug_id: 2
                  factors: [ 1.2, 1 ]
    - chromosome: 7
      genes:
        - name: "Pfcrt"
          multiplicative_effect_on_EC50_for_2_or_more_mutations:
            - drug_id: 3
              factor: 1.0
          average_daily_crs: 0.1290
          # 0.1290 is average of (0.1169,0.0081,0.2621 -  converted from fitness (2.19,2.46,1.83)) from Small-Sander PLOS 2019 paper (Mar 1 23 slides)
          aa_positions:
            - position: 76
              amino_acids: [ 'K', 'T' ]
              daily_crs: [ 0, 0.003875969 ]
              multiplicative_effect_on_EC50:
                - drug_id: 6
                  factors: [ 1, 1.6 ]
                - drug_id: 1å
                  factors: [ 1.1, 1 ]
                - drug_id: 2
                  factors: [ 1, 1.2 ]
            - position: 93
              amino_acids: [ 'T', 'S' ]
              daily_crs: [ 0, 0.0002433748 ] #0.0000313953492  = (0.0081/0.1290)*0.0005
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [ 1, 1.6648 ]
            - position: 97
              amino_acids: [ 'H', 'Y' ]
              daily_crs: [ 0, 0.003875969 ] #0.000500000001
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [ 1, 1.6648 ]
            - position: 145
              amino_acids: [ 'F', 'I' ]
              daily_crs: [ 0, 0.0078751277 ] #0.0010158914733  = (0.2621/0.1290)*0.0005
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [ 1, 2.2226 ]
            - position: 218
              amino_acids: [ 'I', 'F' ]
              daily_crs: [ 0, 0.0035124091 ] #0.0004531007739 = (0.1169/0.1290)*0.0005
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [ 1, 1.6648 ]
            - position: 343
              amino_acids: [ 'M', 'L' ]
              daily_crs: [ 0, 0.003875969 ] #0.000500000001
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [ 1, 1.0 ]
            - position: 353
              amino_acids: [ 'G', 'V' ]
              daily_crs: [ 0, 0.003875969 ] #0.000500000001
              multiplicative_effect_on_EC50:
                - drug_id: 3
                  factors: [ 1, 1.0 ]
        - name: "Pfkaf"
          aa_positions:
            - position: 500
              amino_acids: [ 'x', 'X' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 7
                  factors: [ 1, 1.6 ]
    - chromosome: 13
      genes:
        - name: "Pfkelch13"
          multiplicative_effect_on_EC50_for_2_or_more_mutations:
            - drug_id: 0
              factor: 1.1
          aa_positions:
            - position: 446
              amino_acids: [ 'F', 'I' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 458
              amino_acids: [ 'N', 'Y' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 469
              amino_acids: [ 'C', 'Y' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 476
              amino_acids: [ 'M', 'I' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 493
              amino_acids: [ 'Y', 'H' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 539
              amino_acids: [ 'R', 'T' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 543
              amino_acids: [ 'I', 'T' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 553
              amino_acids: [ 'P', 'L' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 561
              amino_acids: [ 'R', 'H' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 574
              amino_acids: [ 'P', 'L' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 580
              amino_acids: [ 'C', 'Y' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
            - position: 675
              amino_acids: [ 'A', 'V' ]
              daily_crs: [ 0, 0.0005 ]
              multiplicative_effect_on_EC50:
                - drug_id: 0
                  factors: [ 1, 1.6 ]
    - chromosome: 14
      genes:
        - name: "Pfplasmepsin"
          max_copies: 2
          cnv_daily_crs: [ 0, 0.0005 ]
          cnv_multiplicative_effect_on_EC50:
            - drug_id: 3
              #            factors: [ 1, 2.4137931 ]
              factors: [ 1, 1.37 ]
          aa_positions: [ ]

  override_ec50_patterns:
    - pattern: "||||NY1||K......,.||||||............|."
      drug_id: 1
      ec50: 0.8
    - pattern: "||||YY1||K......,.||||||............|."
      drug_id: 1
      ec50: 0.67
    - pattern: "||||NF1||K......,.||||||............|."
      drug_id: 1
      ec50: 0.9
    - pattern: "||||YF1||K......,.||||||............|."
      drug_id: 1
      ec50: 0.8
    - pattern: "||||NY2||K......,.||||||............|."
      drug_id: 1
      ec50: 1.0
    - pattern: "||||YY2||K......,.||||||............|."
      drug_id: 1
      ec50: 0.87
    - pattern: "||||NF2||K......,.||||||............|."
      drug_id: 1
      ec50: 1.1
    - pattern: "||||YF2||K......,.||||||............|."
      drug_id: 1
      ec50: 1.0
    - pattern: "||||NY1||T......,.||||||............|."
      drug_id: 1
      ec50: 0.75
    - pattern: "||||YY1||T......,.||||||............|."
      drug_id: 1
      ec50: 0.6
    - pattern: "||||NF1||T......,.||||||............|."
      drug_id: 1
      ec50: 0.85
    - pattern: "||||YF1||T......,.||||||............|."
      drug_id: 1
      ec50: 0.75
    - pattern: "||||NY2||T......,.||||||............|."
      drug_id: 1
      ec50: 0.95
    - pattern: "||||YY2||T......,.||||||............|."
      drug_id: 1
      ec50: 0.8
    - pattern: "||||NF2||T......,.||||||............|."
      drug_id: 1
      ec50: 1.05
    - pattern: "||||YF2||T......,.||||||............|."
      drug_id: 1
      ec50: 0.95
    - pattern: "||||NY.||K......,.||||||............|."
      drug_id: 2
      ec50: 0.62
    - pattern: "||||YY.||K......,.||||||............|."
      drug_id: 2
      ec50: 0.85
    - pattern: "||||NF.||K......,.||||||............|."
      drug_id: 2
      ec50: 0.5
    - pattern: "||||YF.||K......,.||||||............|."
      drug_id: 2
      ec50: 0.775
    - pattern: "||||NY.||T......,.||||||............|."
      drug_id: 2
      ec50: 0.7
    - pattern: "||||YY.||T......,.||||||............|."
      drug_id: 2
      ec50: 0.9
    - pattern: "||||NF.||T......,.||||||............|."
      drug_id: 2
      ec50: 0.65
    - pattern: "||||YF.||T......,.||||||............|."
      drug_id: 2
      ec50: 0.82
      
  initial_parasite_info:
    - location_id: -1  # -1 indicates all locations
      parasite_info:
        - aa_sequence: "||||YY1||TTHFIMG,x||||||FNCMYRIPRPCA|1"
          prevalence: 0.05
        - aa_sequence: "||||NY1||TTHFIMG,x||||||FNCMYRIPRPCA|1"
          prevalence: 0.05

# ---------------------------------------------------------------
# 12. Drug Parameters
# ---------------------------------------------------------------
drug_parameters:
  # IDs for specific drugs
  artemisinin_drug_id: 0
  lumefantrine_drug_id: 4
  
  drug_db:
    0:
      name: "artemisinin"
      half_life: 0.0
      maximum_parasite_killing_rate: 0.999
      n: 25
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      k: 4
      base_EC50: 0.75
    1:
      name: "lumefantrine"
      half_life: 4.5
      maximum_parasite_killing_rate: 0.99
      n: 20
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      age_specific_drug_absorption: [ 0.7,0.7,0.85,0.85,0.85,0.85,0.85,0.85,0.85,0.85,1.0,1.0,1.0,1.0,1.0 ]
      k: 4
      base_EC50: 0.6
    2:
      name: "amodiaquine"
      half_life: 9.0
      maximum_parasite_killing_rate: 0.95
      n: 19
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      k: 4
      base_EC50: 0.5
    3:
      name: "piperaquine"
      half_life: 28.0
      maximum_parasite_killing_rate: 0.9
      n: 15
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      k: 4
      base_EC50: 0.58
    #MQ
    4:
      name: "Mefloquine"
      half_life: 21.0
      maximum_parasite_killing_rate: 0.9
      n: 15
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      k: 4
      base_EC50: 0.45
      resistant_genes: [ "Pfmdr1" ]
    5:
      name: "SP"
      half_life: 6.5
      maximum_parasite_killing_rate: 0.9
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      n: 15
      k: 4
      base_EC50: 1.08
      resistant_genes: [ ]
    6:
      name: "CQ"
      half_life: 10
      maximum_parasite_killing_rate: 0.95
      n: 19
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      k: 4
      base_EC50: 0.72
    7:
      name: "KAF156"
      half_life: 1.6
      maximum_parasite_killing_rate: 0.99
      n: 15
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      k: 4
      base_EC50: 0.55
    8:
      name: "generic"
      half_life: 7
      maximum_parasite_killing_rate: 0.8
      n: 15
      age_specific_drug_concentration_sd: [ 0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4,0.4 ]
      k: 4
      base_EC50: 0.68

# ---------------------------------------------------------------
# 13. Therapy Parameters
# ---------------------------------------------------------------
therapy_parameters:
  # Testing day for determining if treatment failed
  tf_testing_day: 28
  
  # Treatment failure rate used to determine whether a therapy is "useful"
  tf_rate: 0.1
  
  therapy_db:
    #mono as
    0:
      drug_id: [0]
      dosing_days: [3]
    #mono Lumefaltrine
    1:
      drug_id: [1]
      dosing_days: [3]
    #mono AQ
    2:
      drug_id: [2]
      dosing_days: [3]
    #mono PPQ
    3:
      drug_id: [3]
      dosing_days: [3]
    #mono MQ
    4:
      drug_id: [4]
      dosing_days: [3]
    #mono SP
    5:
      drug_id: [5]
      dosing_days: [3]
    #AL
    6:
      drug_id: [0,1]
      dosing_days: [3]
    #AS-AQ
    7:
      drug_id: [0,2]
      dosing_days: [3]
    # DHA-PPQ
    8:
      drug_id: [0,3]
      dosing_days: [3]
    #AS-MQ
    9:
      drug_id: [0,4]
      dosing_days: [3]
    #TACT DHA-PPQ-MQ
    10:
      drug_id: [0,3,4]
      dosing_days: [3]
    #TACT AL-AQ
    11:
      drug_id: [0,1,2]
      dosing_days: [3]
    #CQ
    12:
      drug_id: [6]
      dosing_days: [3]
    #Generic for Burn-in
    13:
      drug_id: [8]
      dosing_days: [3]

# ---------------------------------------------------------------
# 14. Treatment Strategy Parameters
# ---------------------------------------------------------------
strategy_parameters:
  # Initial treatment strategy ID
  initial_strategy_id: 15
  
  strategy_db:
    0:
      name: SP-AQ-CQ-AL-MFTStrategy
      type: MFT
      therapy_ids: [5,2,12,6]
      distribution: [0.3,0.3,0.3,0.1]
    1:
      name: AL-SFTStrategy
      type: SFT
      therapy_id: 6
    2:
      name: ASAQ-SFTStrategy
      type: SFT
      therapy_id: 7
    3:
      name: CyclingStrategy
      type: Cycling
      therapy_ids: [8,7,6]
      cycling_time: 1825
    4:
      name: AdaptiveCyclingStrategy
      type: AdaptiveCycling
      therapy_ids: [8,7,6]
      trigger_value: 0.1
      delay_until_actual_trigger: 365
      turn_off_days: 365
    5:
      name: MFTStrategy
      type: MFT
      therapy_ids: [8,7,6]
      distribution: [0.333333,0.333333,0.333334]
    6:
      name: AL-ASAQ-DP-MFTRebalancingStrategy1
      type: MFTRebalancing
      therapy_ids: [8,7,6]
      distribution: [0.333333,0.333333,0.333334]
      delay_until_actual_trigger: 365
      update_duration_after_rebalancing: 365
    7:
      name: AL-ASAQ-DP-MFTRebalancingStrategy2
      type: MFTRebalancing
      therapy_ids: [8,7,6]
      distribution: [0.333333,0.333333,0.333334]
      delay_until_actual_trigger: 365
      update_duration_after_rebalancing: 730
    8:
      name: AL-ASAQ-DP-MFTRebalancingStrategy4
      type: MFTRebalancing
      therapy_ids: [8,7,6]
      distribution: [0.333333,0.333333,0.333334]
      delay_until_actual_trigger: 365
      update_duration_after_rebalancing: 1460
    9:
      name: DPM-SFTStrategy
      type: SFT
      therapy_id: 10
    10:
      name: AL-AQ-SFTStrategy
      type: SFT
      therapy_id: 11
    11:
      name: AL-BaseLineStrategy
      type: NestedMFT
      strategy_ids: [1,0]
      start_distribution: [0.05, 0.95]
      peak_distribution: [0.8,0.2]
      peak_after: 3650
    12:
      name: ASAQ-BaseLineStrategy
      type: NestedMFT
      strategy_ids: [2,0]
      start_distribution: [0.05, 0.95]
      peak_distribution: [0.8,0.2]
      peak_after: 3650
    13:
      name: BaseLineStrategy
      type: NestedMFTMultiLocation
      strategy_ids: [0,1]
      start_distribution: [[0.05, 0.95]]
      peak_distribution: [[0.8,0.2]]
      peak_after: 3650
    14:
      name: DHAPPQ-SFTStrategy
      type: SFT
      therapy_id: 8
    15:
      name: Burnin-SFTStrategy
      type: SFT
      therapy_id: 13

# ---------------------------------------------------------------
# 15. Epidemiological Parameters
# ---------------------------------------------------------------
epidemiological_parameters:
  # Days from end of liver-stage infection to appearance of symptoms
  days_to_clinical_under_five: 4
  days_to_clinical_over_five: 6
  
  # Days for parasites to develop mature gametocytes after exiting liver stage
  # Note: There are no explicit gametocytes in version 3.0.2 of the simulation
  days_mature_gametocyte_under_five: 4
  days_mature_gametocyte_over_five: 6
  
  # Probability that a patient completes a course of treatment
  p_compliance: 1
  
  # Guarantees that the minimum number of dosing days for a poorly complying patient is still 1
  min_dosing_days: 1
  
  # Relative biting rates for individuals
  relative_biting_info:
    max_relative_biting_value: 35
    min_relative_biting_value: 1.0
    number_of_biting_levels: 100
    biting_level_distribution:
      distribution: Gamma
      Gamma:
        mean: 5
        sd: 10
  
  # Gametocyte levels under artemisinin action and when full
  gametocyte_level_under_artemisinin_action: 1.0
  gametocyte_level_full: 1.0
  
  # Parameters determining the probability a mosquito becomes infected based on the host's parasitemia level
  relative_infectivity:
    sigma: 3.91
    ro: 0.00031
    blood_meal_volume: 3  # Average blood meal volume in microliters
  
  # Probability of relapse after no treatment or treatment failure
  p_relapse: 0.01
  
  # Number of days before a relapse can occur
  relapse_duration: 30
  
  # Relapse rate used to increase parasite density after treatment failure
  # Multiply by sqrt(20) per day
  relapseRate: 4.4721
  
  # Minimum update frequency for a host's attributes (especially parasite density)
  update_frequency: 7
  
  # Allows new co-infections to cause symptoms in infected but asymptomatic hosts
  allow_new_coinfection_to_cause_symptoms: true
  
  # Window size for observing treatment failure rates
  tf_window_size: 60
  
  # Fraction of mosquitoes experiencing interrupted feeding
  fraction_mosquitoes_interrupted_feeding: 0.0
  
  # Inflation factor for certain calculations
  inflation_factor: 0.01

# ---------------------------------------------------------------
# 16. Mosquito Parameters
# ---------------------------------------------------------------
mosquito_parameters:
  mosquito_config:
    interrupted_feeding_rate: [0.19]
    prmc_size: 100
  
  # Within-host induced free recombination
  within_host_induced_free_recombination: true

# ---------------------------------------------------------------
# 17. Events
# ---------------------------------------------------------------
events:
  - name: "turn_off_mutation"
    info:
      - day: 2000/1/1
  - name: "turn_on_mutation"
    info:
      - day: 2010/1/1
  - name: "change_treatment_strategy"
    info:
      - day: 2010/1/1
        strategy_id: 3
  - name: "change_treatment_coverage"
    info:
      - type: "SteadyTCM"
        day: 2010/1/1
        p_treatment_for_less_than_5_by_location: [0.750000]
        p_treatment_for_more_than_5_by_location: [0.750000]
  - name: "change_mutation_probability_by_locus"
    info:
      - day: 2000/1/1
        value: 0.0
      - day: 2010/1/1
        value: 0.001
